Loading...

AME: Margin Management And Organic Sales Trends Will Influence Multi-Industry Outlook

Published
20 Aug 24
Updated
06 Jun 26
Views
251
06 Jun
US$226.55
AnalystConsensusTarget's Fair Value
US$259.16
12.6% undervalued intrinsic discount
Loading
1Y
27.0%
7D
0.3%

Author's Valuation

US$259.1612.6% undervalued intrinsic discount

AnalystConsensusTarget Fair Value

Last Update 06 Jun 26

AME: Defense Orders And First Aviation Deal Will Shape Future Upside

Analysts have increased their price targets on AMETEK by about $9 to $10 per share, citing updated models after recent results and new coverage that reflects their current views on the company’s earnings profile and valuation multiples.

Analyst Commentary

Bullish and cautious voices are both active around AMETEK right now, with several recent research updates reshaping how some analysts think about the valuation, earnings path, and near term trading setup.

Bullish Takeaways

  • Bullish analysts who raised price targets by about $9 to $10 per share are signaling more confidence in their updated models, which reflect recent results and refreshed earnings estimates.
  • New coverage with a positive stance and the initiation of a bullish view point to expectations that AMETEK can execute on its current plan in a way that supports the existing valuation or possibly a higher one.
  • The short term buy idea from one major firm indicates that some see an attractive near term risk reward, with the stock viewed as appealing for investors who are comfortable with shorter holding periods.
  • The revision of a target to $235 in a recent model update, tied to actual Q4 results and rolled forward estimates, shows continued interest in the stock at levels that reflect current earnings assumptions and not just past performance.

Bearish Takeaways

  • The reduction of one price target by $10 highlights that not all analysts share the same level of optimism, and some see less upside at previous target levels based on their revised assumptions.
  • Where analysts keep more neutral ratings alongside updated targets, it suggests a view that current pricing already reflects much of the expected execution, limiting room for valuation expansion without new information.
  • Differences between target increases and cuts show that there is debate about how much earnings power should be capitalized into the share price, which can cap enthusiasm for investors looking for a clear consensus.
  • Short term oriented positive calls can also imply that some analysts see the stock more as a trading idea than a clear long term outperformer at current valuations, which may restrain conviction for longer horizon investors.

What’s in the News

  • AMETEK reported Q1 2026 revenue of $1.93b, up 11.3% year over year, with earnings per share of $1.97 that were 3.8% above Wall Street estimates, supported by 10.6% growth in electronic instruments sales and 12.9% growth in electromechanical sales, according to company results dated 30 April 2026.
  • The company highlighted record EBITDA, margin expansion, and 22% organic order growth in Q1 2026, driven by demand in aerospace, defense, automation, process instrumentation, and semiconductor markets, based on the same 30 April 2026 results.
  • AMETEK raised its full year 2026 adjusted EPS guidance to a range of $7.94 to $8.14 and indicated expectations for high single digit sales growth and EPS growth of 7% to 10%, as outlined in its 30 April 2026 update.
  • AMETEK completed the acquisition of First Aviation Services, adding defense and aviation maintenance, repair and overhaul operations and six U.S. centers of excellence to its Electromechanical Group, according to company announcements on 26 May 2026.
  • The company issued GAAP earnings guidance calling for second quarter 2026 sales to be up high single digits year over year with EPS in a range of $1.73 to $1.77, and full year 2026 sales up high single digits with GAAP EPS between $7.03 and $7.23, based on a guidance update dated 28 May 2026.

Valuation Changes

  • Fair Value: $259.16 is unchanged in the updated model, indicating no shift in the core valuation output.
  • Discount Rate: The discount rate has fallen slightly from 9.83% to 9.58%, reflecting a modestly lower required return in the model.
  • Revenue Growth: Revenue growth remains effectively stable at about 6.11%, with only a very small adjustment in the updated assumptions.
  • Net Profit Margin: The net profit margin is essentially unchanged around 21.79%, with only a minimal refinement in the model input.
  • Future P/E: The future P/E has edged slightly lower from 38.88x to 38.62x, pointing to a small reduction in the valuation multiple used in the projections.
0 viewsusers have viewed this narrative update

Key Takeaways

  • Expansion in digital automation and sustainability markets, combined with disciplined acquisitions, is driving recurring revenue growth and increasing margins across key sectors.
  • Strong R&D investment enables ongoing innovation, supporting high-margin product launches and steady gains in market share and profitability.
  • Weakness in key end markets, reliance on acquisitions, and digital competition pose sustained risks to growth, margins, and long-term profitability.

Catalysts

About AMETEK
    Manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally.
What are the underlying business or industry changes driving this perspective?
  • Adoption of digital reality, automation, and advanced metrology solutions is accelerating across key end markets such as aerospace, defense, and architecture-recently reinforced by the FARO Technologies acquisition-expanding AMETEK's addressable market and supporting both revenue and margin growth through higher value, software-enabled recurring revenue streams.
  • Growing global focus on sustainability and energy efficiency, alongside regulatory requirements across sectors (e.g., energy, grid modernization, environmental labs), is driving long-term demand for high-precision analytical and monitoring instrumentation, favoring AMETEK's portfolio and supporting steady revenue and market share gains.
  • Sustained robust investment in R&D-reflected in a high vitality index and recent product launches (e.g., SPECTROGREEN MS for environmental and pharmaceutical analysis)-positions AMETEK for ongoing innovation, higher-margin product introductions, and net margin expansion as industries demand more sophisticated, reliable measurement solutions.
  • EMG and Automation segments are inflecting upwards, with destocking now complete and record orders translating to accelerating organic growth and strong core margin expansion; this shift is poised to further enhance operating leverage and group EBITDA growth in coming quarters.
  • Ongoing successful execution of a disciplined M&A strategy, leveraging a robust acquisition pipeline and significant balance sheet capacity, provides a catalyst for compounding top-line and EPS growth, while integration synergies and operational excellence drive expansion of operating and EBITDA margins.
AMETEK Earnings and Revenue Growth

AMETEK Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming AMETEK's revenue will grow by 6.1% annually over the next 3 years.
  • Analysts assume that profit margins will increase from 20.1% today to 21.8% in 3 years time.
  • Analysts expect earnings to reach $2.0 billion (and earnings per share of $8.67) by about June 2029, up from $1.5 billion today. The analysts are largely in agreement about this estimate.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 38.6x on those 2029 earnings, up from 34.0x today. This future PE is greater than the current PE for the US Electrical industry at 36.3x.
  • Analysts expect the number of shares outstanding to decline by 0.76% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 9.58%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • Persistent weakness in the process and analytical segment, particularly due to sluggish conditions in semiconductor and research/academia end markets-segments that together represent a sizable portion of AMETEK's sales-may limit organic revenue growth and create sustained headwinds for overall top-line expansion.
  • Prolonged uncertainty in global trade dynamics, including tariffs and delays in project funding (especially in China), introduces volatility that could disrupt order timing, reduce visibility, and impact revenue recognition, potentially compressing margins if mitigation actions lose effectiveness.
  • Overreliance on M&A for growth-as indicated by the expectation to drive enhanced top-line and margin expansion through acquisitions like FARO and Paragon-raises the risk of integration missteps, overpayment, or underperformance, which could dilute return on invested capital and lead to goodwill impairments, thus affecting net income.
  • Competitive threats from industry digitization and potential commoditization in core instrumentation markets, especially as cloud-based analytics and software-driven solutions become more prevalent, may erode AMETEK's hardware-centric value proposition and pressure long-term net margins.
  • Ongoing delays and reductions in academic and government research funding, which constitute roughly 10% of company revenues and are currently cited as a headwind, could persist longer term, capping growth opportunities in those end markets and dampening earnings potential.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $259.16 for AMETEK based on their expectations of its future earnings growth, profit margins and other risk factors.
  • However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $280.0, and the most bearish reporting a price target of just $217.0.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $9.1 billion, earnings will come to $2.0 billion, and it would be trading on a PE ratio of 38.6x, assuming you use a discount rate of 9.6%.
  • Given the current share price of $226.55, the analyst price target of $259.16 is 12.6% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on AMETEK?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives